Treating hepatitis C infection in liver transplant recipients

Norah A. Terrault, Marina Berenguer – 25 July 2006 – Chronic infection with hepatitis C virus (HCV) is a growing problem worldwide, with up to 300 million individuals infected, and those with chronic infection are at risk for cirrhosis and hepatocellular carcinoma. HCV infection is the most common indication for liver transplantation in the United States and Europe. Unfortunately, although transplantation is effective for treating decompensated cirrhosis and limited hepatocellular carcinoma associated with hepatitis C, HCV reinfection is virtually the rule among transplant recipients.

Vascular reconstruction and complications in living donor liver transplantation in infants weighing less than 6 kilograms: The Kyoto experience

Yasumasa Shirouzu, Mureo Kasahara, Daisuke Morioka, Seisuke Sakamoto, Kaoru Taira, Kenji Uryuhara, Kohei Ogawa, Yasutsugu Takada, Hiroto Egawa, Koichi Tanaka – 25 July 2006 – Smaller‐size infants undergoing living‐donor liver transplantation (LDLT) are at increased risks of vascular complications because of their smaller vascular structures in addition to vascular pedicles of insufficient length for reconstruction. Out of 585 child patients transplanted between June 1990 and March 2005, 64 (10%) weighing less than 6 kg underwent 65 LDLTs.

Disseminated coccidioidomycosis in a liver transplant recipient with negative serology: Use of polymerase chain reaction

Maha A. Assi, Matthew J. Binnicker, Nancy L. Wengenack, Paul J. Deziel, Andrew D. Badley – 25 July 2006 – Coccidioidomycosis has been previously described in recipients of solid organ transplantation, especially in patients who have lived in or have visited areas endemic for Coccidioides spp. We present a case of coccidioidomycosis in a liver transplant recipient with several unique aspects, including negative serology and positive polymerase chain reaction results. Liver Transpl 12:1290–1292, 2006. © 2006 AASLD.

Subscribe to